About Luas Diagnostics
Luas Diagnostics is a company based in Guildford (United Kingdom) founded in 2020. Luas Diagnostics has raised $949.08 thousand across 4 funding rounds. The company has 3 employees as of June 30, 2022. Luas Diagnostics offers products and services including Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests. Luas Diagnostics operates in a competitive market with competitors including Dexcom, Livongo, Bigfoot Biomedical, Prenetics and Senseonics, among others.
- Headquarter Guildford, United Kingdom
- Employees 3 as on 30 Jun, 2022
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Luas Diagnostics Ltd
- Date of Incorporation 08 Jun, 2020
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$949.08 K (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
-
Employee Count
3
as on Jun 30, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Luas Diagnostics
Luas Diagnostics offers a comprehensive portfolio of products and services, including Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests.
Home-to-laboratory test for Group B Streptococcus in pregnancy.
Single-use self-test for detecting HIV-1 and HIV-2 antibodies.
Range of tests for various infectious diseases at home or professionally.
Tests for early detection of cancer to improve clinical outcomes.
People of Luas Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Luas Diagnostics
Luas Diagnostics has successfully raised a total of $949.08K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(29 Sep 2020)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Seed - Luas Diagnostics | Valuation |
investors |
|
| Apr, 2021 | Amount | Seed - Luas Diagnostics | Valuation |
investors |
|
| Jan, 2021 | Amount | Seed - Luas Diagnostics | Valuation |
investors |
|
Investments & Acquisitions by Luas Diagnostics
Financial Statements - Luas Diagnostics
Luas Diagnostics Comparisons
Competitors of Luas Diagnostics
Luas Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Bigfoot Biomedical, Prenetics and Senseonics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| domain | founded_year | HQ Location |
Provider of smart devices for diabetes management for patients and doctors
|
|
| domain | founded_year | HQ Location |
Developer of a closed-loop automated insulin delivery system
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| domain | founded_year | HQ Location |
Provider of workforce healthcare solutions
|
Frequently Asked Questions about Luas Diagnostics
Luas Diagnostics was founded in 2020.
Luas Diagnostics is headquartered in Guildford, United Kingdom.
Luas Diagnostics is a funded company, having raised a total of $949.08K across 4 funding rounds to date. The company's 1st funding round was a Seed of $416.77K, raised on Sep 29, 2020.
As of Jun 30, 2022, the latest employee count at Luas Diagnostics is 3.
Founded in 2020 and based in Guildford, United Kingdom, operations are focused on the health diagnostics sector. Sensors and a connected app are developed for diabetes management. A portable diagnostic device is utilized to detect enzyme-substrate complexes on electrodes in glucose monitors. Presence of drugs or metabolites in samples is identified at the electrode, with no drug sample required in the tested material.
Luas Diagnostics's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.
Luas Diagnostics offers Strepelle, HIV Self-Test, Other Infectious Diseases Tests, and Cancer Tests.
The valuation of Luas Diagnostics is $3.01M as of Apr 2023.